{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:50:20Z","timestamp":1760907020689},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.dsx.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T16:21:42Z","timestamp":1534004502000},"page":"24-29","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adipocytokines, inflammatory, epigenetic instability & angiogenesis biomarkers in type 2 diabetic Egyptian women with breast cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Heba Bassiony","family":"Ghanem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa Ali","family":"El-Benhawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Shahba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.dsx.2018.08.005_bib1","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1194\/jlr.R066514","article-title":"Lipid signaling and lipotoxicity in metabolic inflammation: indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.dsx.2018.08.005_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9382092","article-title":"Associations of A-FABP with anthropometric and metabolic indices and inflammatory cytokines in obese patients with newly diagnosed type 2 diabetes","volume":"2016","author":"Niu","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.dsx.2018.08.005_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What we talk about when we talk about fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2018.08.005_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000368510","article-title":"Tumor necrosis factor-alpha and 8-hydroxy-2'-deoxyguanosine are associated with elevated urinary Angiopoietin-2 level in type 2 diabetic patients with albuminuria","volume":"40","author":"Hea","year":"2015","journal-title":"Kidney Blood Pres Res"},{"key":"10.1016\/j.dsx.2018.08.005_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.dsx.2018.08.005_bib6","first-page":"2640","article-title":"Adipocyte\/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice","volume":"118","author":"Furuhashi","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.dsx.2018.08.005_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs-mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.dsx.2018.08.005_bib8","article-title":"Differential expression of lipid metabolism-related proteins in different breast cancer subtypes","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2018.08.005_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.08.005_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpba.2004.04.016","article-title":"Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients","volume":"36","author":"Xu","year":"2004","journal-title":"J\u00a0Pharmaceut Biomed Anal"},{"key":"10.1016\/j.dsx.2018.08.005_bib11","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1007\/s13277-016-4873-9","article-title":"The role of oxidative stress on breast cancer development and therapy","volume":"37","author":"Hecht","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.dsx.2018.08.005_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1073\/pnas.022630199","article-title":"Reactive oxygen generated by Nox1 triggers the angiogenic switch","volume":"99","author":"Arbiser","year":"2002","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"10.1016\/j.dsx.2018.08.005_bib13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/ars.2011.4489","article-title":"NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts","volume":"16","author":"Coso","year":"2012","journal-title":"Antioxidants Redox Signal"},{"issue":"3","key":"10.1016\/j.dsx.2018.08.005_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","article-title":"VEGF as a therapeutic target in cancer","volume":"69","author":"Ferrara","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.dsx.2018.08.005_bib15","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.2337\/diacare.27.12.2918","article-title":"Plasma vascular endothelial growth factor, Angiopoietin-1, and Angiopoietin-2 in diabetes implications for cardiovascular risk and effects of multifactorial intervention","volume":"27","author":"Lim","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.08.005_bib16","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1038\/srep28080","article-title":"Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness","volume":"6","author":"Peng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dsx.2018.08.005_bib17","doi-asserted-by":"crossref","first-page":"36860","DOI":"10.1038\/srep36860","article-title":"Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress","volume":"6","author":"Dong","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.dsx.2018.08.005_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.08.005_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"91","author":"Elston","year":"1991","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.dsx.2018.08.005_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/j.1550-8528.1994.tb00047.x","article-title":"A\u00a0treatise on a man and the development of his faculties","volume":"2","author":"Quetelet","year":"1994","journal-title":"Obes Res"},{"issue":"2","key":"10.1016\/j.dsx.2018.08.005_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jcp.22.2.158","article-title":"Determination of blood glucose using oxidase-peroxidase system with a non-carcinogenic chromogen","volume":"22","author":"Tinder","year":"1969","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.dsx.2018.08.005_bib22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/clinchem\/19.12.1350","article-title":"Enzymatic determination of cholesterol","volume":"19","author":"Richmond","year":"1973","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2018.08.005_bib23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","article-title":"Serum triglycerides determined colometrically with an enzyme that produces hydrogen peroxide","volume":"28","author":"Fossati","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2018.08.005_bib24","first-page":"707","article-title":"Determination of high density lipoprotein cholesterol","volume":"42","author":"Gordon","year":"1977","journal-title":"J\u00a0Med"},{"key":"10.1016\/j.dsx.2018.08.005_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2018.08.005_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0076-6879(95)52023-6","article-title":"Thioredoxin and thioredoxin reductase","volume":"252","author":"Holmgren","year":"1995","journal-title":"Meth Enzymol"},{"issue":"11","key":"10.1016\/j.dsx.2018.08.005_bib27","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.dsx.2018.08.005_bib28","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/j.bmcl.2004.06.057","article-title":"Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target","volume":"14","author":"Lehmann","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.dsx.2018.08.005_bib29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2337\/db13-0436","article-title":"FABP4 Attenuates PPARc and adipogenesis and is inversely correlated with PPARc in adipose tissues","volume":"63","author":"Garin-Shkolnik","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.08.005_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-009-0577-9","article-title":"Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients","volume":"119","author":"Hancke","year":"2010","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.dsx.2018.08.005_bib31","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","article-title":"Energy metabolism in tumor cells","volume":"274","author":"Moreno-Sanchez","year":"2007","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.dsx.2018.08.005_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-10-1195","article-title":"FABP4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women","volume":"164","author":"Terra","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dsx.2018.08.005_bib33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/00029330-200709020-00009","article-title":"Adipocytokines and breast cancer risk","volume":"120","author":"Hou","year":"2007","journal-title":"Chinese Med J"},{"key":"10.1016\/j.dsx.2018.08.005_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","article-title":"Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?","volume":"56","author":"Kralisch","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2018.08.005_bib35","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.4049\/jimmunol.177.11.7794","article-title":"Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2","volume":"177","author":"Rolph","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.dsx.2018.08.005_bib36","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2164-16-S1-S11","article-title":"Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein 4: is lipid metabolism associated with breast cancer?","volume":"16","author":"Merdad","year":"2015","journal-title":"BMC Genom"},{"key":"10.1016\/j.dsx.2018.08.005_bib37","first-page":"119","article-title":"8-hydroxyguanine in urine and serum as an oxidative stress marker: effects of diabetes and aging","volume":"35","author":"Li","year":"2013","journal-title":"J\u00a0UOEH"},{"issue":"1","key":"10.1016\/j.dsx.2018.08.005_bib38","article-title":"Decreased thioredoxin reductase activity in endothelial cells exposed to high glucose is associated with protein tyrosine nitration and interaction with caveolin 1","volume":"27","author":"Lamoke","year":"2013","journal-title":"Faseb J"},{"issue":"9","key":"10.1016\/j.dsx.2018.08.005_bib39","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/carcin\/20.9.1657","article-title":"Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase","volume":"20","author":"Ganther","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.dsx.2018.08.005_bib40","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.2337\/db15-0746","article-title":"Kallikrein-kinin system: an emerging competitor or collaborator for VEGF in diabetic macular edema?","volume":"64","author":"Murakami","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.08.005_bib41","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3390\/ijms17091498","article-title":"Moving past anti-VEGF: novel therapies for treating diabetic retinopathy","volume":"17","author":"Bolinger","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.dsx.2018.08.005_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148774","article-title":"ZEB1 upregulates VEGF expression and stimulates angiogenesis in breast cancer","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2018.08.005_bib43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3892\/mco.2015.574","article-title":"High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer","volume":"3","author":"Sa-Nguanraksa","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.dsx.2018.08.005_bib44","first-page":"23","article-title":"Fatty Acid-Binding Protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases","volume":"8","author":"Furuhashi","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"issue":"2","key":"10.1016\/j.dsx.2018.08.005_bib45","first-page":"203","article-title":"Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies","volume":"24","author":"Pluda","year":"1997","journal-title":"Semin Oncol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T16:45:28Z","timestamp":1604767528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118302947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1871402118302947"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.08.005","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipocytokines, inflammatory, epigenetic instability & angiogenesis biomarkers in type 2 diabetic Egyptian women with breast cancer","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}